Heterotypic Condensate Formation by Prion Proteins and Pro-Inflammatory S100A9
- 1Life Sciences Center, Vilnius University
Abstract
Liquid-liquid phase separation (LLPS) of biomacromolecules has been shown to influence a large variety of biological processes via the formation of membraneless organelles. Aberrant LLPS, however, has been implicated in a number of oncological and neurodegenerative disorders. Proteins related to Alzheimer's, Parkinson's diseases and other major amyloidoses have all been shown to form these condensates. Interestingly, some amyloidogenic proteins were demonstrated to form heterotypic droplets, where both molecules coexisted within the same condensate and affected each other's aggregation. While such cross-interactions have been reported numerous times under non-LLPS conditions, the heterotypic droplet assemblies were only shown for a very limited number of amyloidogenic proteins. In this work, we examine heterotypic LLPS of prion proteins and the pro-inflammatory S100A9, whose cross-interaction under non-LLPS conditions we confirmed in a previous work. The results show that this interaction under condensation-promoting conditions enhances their aggregation, leading to the formation of a higher concentration of amyloid structures. These findings suggest that the pro-inflammatory S100A9 may have a critical role in promoting prion protein aggregation via the assembly of heterotypic condensates under high molecular crowding conditions.
Related
- Proteome-scale quantification of the interactions driving condensate formation of intrinsically disordered proteins
- Heterotypic interactions and sequence features modulate cellular reflectin condensate dynamics
- The effects of pH on cortex and condensate formation
- Contribution of chromosome-naïve transposon-seeded network of DNA templates to intracellular pools of protein dimers of liquid-liquid phase-separated condensate-forming proteins
- SOP-Multi-π: A Two-Site Coarse-Grained Model with Rescaled Aromatic Interactions to Bridge Single-Chain Ensembles and Condensate Phase Behavior of IDPs and Multidomain Proteins
BibTeX
@misc{veiveris2026heterotypic,
title = {{Heterotypic Condensate Formation by Prion Proteins and Pro-Inflammatory S100A9}},
author = {D. Veiveris and V. Karalkeviciute and K. Mikalauskaite and D. Sulskis and M. Ziaunys},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.02.756240},
url = {https://www.biorxiv.org/content/10.64898/2026.10.02.756240v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Heterotypic Condensate Formation by Prion Proteins and Pro-Inflammatory S100A9
AU - D. Veiveris
AU - V. Karalkeviciute
AU - K. Mikalauskaite
AU - D. Sulskis
AU - M. Ziaunys
PY - 2026
DA - 2026/10/02
PB - bioRxiv
DO - 10.64898/2026.10.02.756240
UR - https://www.biorxiv.org/content/10.64898/2026.10.02.756240v1
AB - Liquid-liquid phase separation (LLPS) of biomacromolecules has been shown to influence a large variety of biological processes via the formation of membraneless organelles. Aberrant LLPS, however, has been implicated in a number of oncological and neurodegenerative disorders. Proteins related to Alzheimer's, Parkinson's diseases and other major amyloidoses have all been shown to form these condensates. Interestingly, some amyloidogenic proteins were demonstrated to form heterotypic droplets, where both molecules coexisted within the same condensate and affected each other's aggregation. While such cross-interactions have been reported numerous times under non-LLPS conditions, the heterotypic droplet assemblies were only shown for a very limited number of amyloidogenic proteins. In this work, we examine heterotypic LLPS of prion proteins and the pro-inflammatory S100A9, whose cross-interaction under non-LLPS conditions we confirmed in a previous work. The results show that this interaction under condensation-promoting conditions enhances their aggregation, leading to the formation of a higher concentration of amyloid structures. These findings suggest that the pro-inflammatory S100A9 may have a critical role in promoting prion protein aggregation via the assembly of heterotypic condensates under high molecular crowding conditions.
ER -